According to the latest news, Ruby-O™, an advanced omega-3 phospholipid optimizes the intake of docosahexaenoic (DHA) and eicosapentanoic (EPA) acids. This news was published in the leading information source, Natural Products Insider.
The need for DHA and EPA for a healthy operation of the human body is not a hidden fact. However, these essential nutrients are not produced by the body and need to be supplemented through diet. Fish/animal oils account as a primary ingredient in several supplement categories such as for the brain, heart, joint, vision, and pre-and post-natal care. Omega-3s are difficult to absorb and the market’s major efforts are on to address their bioavailability.
Naturmega’s Ruby-O™ brings solves the problem of omega-3 bioavailability, by introducing a phospholipid ingredient that boosts the absorption of EPA/DHA. Since it is composed of a hydrophilic “head” and a hydrophobic “tail,” it helps in better dispersal of phospholipid-based oils by our body’s water-based cells. A recent clinical study to compare Ruby-O™ bioavailability with that of krill oil showed that a single dose of Ruby-O™ resulted in higher average levels of EPA, DHA and EPA+DHA than after a single dose of the krill oil product during the first 10 hours. Ruby-O™ is also unique because high-quality fish oil is used for its production and Naturmega has created its customized concentrates using molecular distillation.
Source: Capitalizing on a targeted, optimized approach to omega-3 supplementation. Natural Products Insider. 3 March, 2023.
https://www.naturalproductsinsider.com/ingredients/capitalizing-targeted-optimized-approach-omega-3-supplementation-article
